My project utilises the natural genetic variation between patients to identify cellular HIV-1 regulatory factors by conducting an infectivity screen in characterised induced pluripotent stem cells.
I obtained my BSc in Biomedical Science from Imperial College London where I specialised in immunity and infection. Due to my passion for translational research, following my BSc I pursued a job in the biotech industry. I completed a 10-month internship as part of the research and discovery team at Orchard Therapeutics, a biotech company specialising in gene therapy.
My PhD is a collaboration between King’s College London and Orchard therapeutics, made possible by the MRC DTP iCase Studentship programme. This partnership was perfect for me as it allowed me to further my industrial experience whilst receiving the high quality research training provided by the MRC DTP. My project utilises induced pluripotent stem cells (iPSCs) to further our knowledge of human immunodeficiency virus-1 (HIV-1) and its interactions with its host.